Actively Recruiting
The St. Paul's Hospital Advanced Endoscopic Resection Centre Cohort for Colorectal Neoplasia (SPARC-C): A Prospective Observational Study
Led by University of British Columbia · Updated on 2026-05-15
3500
Participants Needed
6
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of British Columbia
Lead Sponsor
C
CentraCare
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are conducting the SPARC-C study, a prospective, multi-institutional observational study focused on patients with large (20mm or larger) non-pedunculated colorectal polyps (LNPCPs). The study aims to evaluate current management strategies for these polyps using minimally invasive endoscopic techniques, while collecting detailed data on patient characteristics, lesion details, procedural outcomes, and clinical results over time. This research is based at multiple hospitals and plans to enroll around 3500 participants over 10 years. Participants undergo endoscopic tissue resection procedures such as endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), or cold snare resection (CSR), which are standard treatments for large colorectal polyps. The study observes how these techniques are applied, including any technical modifications or auxiliary strategies used to reduce risks like bleeding, injury, perforation, or polyp recurrence. The study does not assign treatments but follows patients managed according to current care standards. During the study, participants' outcomes such as technical and clinical success of the endoscopic procedures are monitored, along with adverse events like bleeding or perforation, and rates of recurrence or surgery referral. Data collection includes clinical assessments and procedural details up to 6 months afterward. This long-term observational study helps refine endoscopic management of LNPCPs and supports development of decision support tools using artificial intelligence.
CONDITIONS
Brief Title
St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years of age or older referred for management of a large non-pedunculated colorectal polyp
- Able to provide informed consent
You will not qualify if you...
- Unable to provide informed consent
- Pregnant or lactating women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single procedure visit
Participants undergo endoscopic resection techniques for removal of large colorectal polyps.
1 visit (in-person)
Duration - 6 months
Participants are observed for clinical success, technical success, and any adverse outcomes following the endoscopic procedure.
Follow-up visits as scheduled up to 6 months
Trial Site Locations
Total: 6 locations
1
St. Cloud Hospital
Saint Cloud, Minnesota, United States, 56303
Actively Recruiting
2
Mount Saint Joseph Hospital
Vancouver, British Columbia, Canada, V5T 3N4
Active, Not Recruiting
3
Vancouver General Hospital
Vancouver, British Columbia, Canada, V6B2W6
Actively Recruiting
4
St. Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6
Actively Recruiting
5
Pacific Gastroenterology Associates
Vancouver, British Columbia, Canada, V6Z 2K5
Actively Recruiting
6
Hadassah Ein Kerem Hospital
Jerusalem, Israel
Active, Not Recruiting
Research Team
S
Shirley X Jiang, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here